Search research articles
Contact Us
Filters
Showing results (61-70 of 118) with videos related to
Page
of 12
Sort By:
Health Economics
|
October 5, 2017
Social value and individual choice: The value of a choice-based decision-making process in a collectively funded health system
Manuel Antonio Espinoza, Andrea Manca, Karl Claxton, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
April 6, 2007
Efficiency, equity, and budgetary policies: informing decisions using mathematical programming
David M Epstein, Zaid Chalabi, Karl Claxton, et al.
Gaceta Sanitaria
|
March 7, 2025
The opportunity cost of funding new medicines: an attempt to measure the invisible
Laura Vallejo-Torres, David J Vanness, Mike Paulden, et al.
Pharmacoeconomics
|
April 12, 2006
Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment
Zoë Philips, Laura Bojke, Mark Sculpher, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
June 20, 2014
The value of heterogeneity for cost-effectiveness subgroup analysis: conceptual framework and application
Manuel A Espinoza, Andrea Manca, Karl Claxton, et al.
BMJ Global Health
|
October 21, 2020
Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries
Jessica Ochalek, Kaja Abbas, Karl Claxton, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
July 29, 2008
Value of information and value of implementation: application of an analytic framework to inform resource allocation decisions in metastatic hormone-refractory prostate cancer
Ties Hoomans, Elisabeth A L Fenwick, Steve Palmer, et al.
Health Economics
|
January 16, 2024
Achieving dynamic efficiency in pharmaceutical innovation: Identifying the optimal share of value and payments required
Beth Woods, James Lomas, Mark Sculpher, et al.
Health Economics
|
December 15, 2010
Discounting and decision making in the economic evaluation of health-care technologies
Karl Claxton, Mike Paulden, Hugh Gravelle, et al.
Health Economics
|
August 24, 2017
How to design the cost-effectiveness appraisal process of new healthcare technologies to maximise population health: A conceptual framework
Kasper M Johannesen, Karl Claxton, Mark J Sculpher, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 118) with videos related to
Sort By:
Page
of 12
Health Economics
|
October 5, 2017
Social value and individual choice: The value of a choice-based decision-making process in a collectively funded health system
Manuel Antonio Espinoza, Andrea Manca, Karl Claxton, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
April 6, 2007
Efficiency, equity, and budgetary policies: informing decisions using mathematical programming
David M Epstein, Zaid Chalabi, Karl Claxton, et al.
Gaceta Sanitaria
|
March 7, 2025
The opportunity cost of funding new medicines: an attempt to measure the invisible
Laura Vallejo-Torres, David J Vanness, Mike Paulden, et al.
Pharmacoeconomics
|
April 12, 2006
Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment
Zoë Philips, Laura Bojke, Mark Sculpher, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
June 20, 2014
The value of heterogeneity for cost-effectiveness subgroup analysis: conceptual framework and application
Manuel A Espinoza, Andrea Manca, Karl Claxton, et al.
BMJ Global Health
|
October 21, 2020
Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries
Jessica Ochalek, Kaja Abbas, Karl Claxton, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
July 29, 2008
Value of information and value of implementation: application of an analytic framework to inform resource allocation decisions in metastatic hormone-refractory prostate cancer
Ties Hoomans, Elisabeth A L Fenwick, Steve Palmer, et al.
Health Economics
|
January 16, 2024
Achieving dynamic efficiency in pharmaceutical innovation: Identifying the optimal share of value and payments required
Beth Woods, James Lomas, Mark Sculpher, et al.
Health Economics
|
December 15, 2010
Discounting and decision making in the economic evaluation of health-care technologies
Karl Claxton, Mike Paulden, Hugh Gravelle, et al.
Health Economics
|
August 24, 2017
How to design the cost-effectiveness appraisal process of new healthcare technologies to maximise population health: A conceptual framework
Kasper M Johannesen, Karl Claxton, Mark J Sculpher, et al.
Page
of 12